NCT02664831
- Conditions
- Body Weight, Brain Diseases, Brain Ischemia, +23 more
- Locations
-
- Maine Medical Center Portland, Maine, United States
Clinical trial condition
Fibromatosis, Gingival, 2
Explore clinical trials studying Fibromatosis, Gingival, 2. Study availability and eligibility vary by location and protocol.
8 public trials
1 recruiting study
Fibromatosis, Gingival, 2 trial results
NCT04210375
- Conditions
- Cardiovascular Diseases, Fibromatosis, Gingival, 2, Heart Diseases, +2 more
- Locations
-
- University of Arizona College of Medicine Tucson, Arizona, United States
- Stanford University Medical Center Stanford, California, United States
- Harvard Medical School/ Massachusetts General Hospital Boston, Massachusetts, United States
- Cleveland Clinic Cleveland, Ohio, United States
NCT04391491
- Conditions
- Angina Pectoris, Cardiovascular Diseases, Fibromatosis, Gingival, 2, +11 more
- Locations
-
- Anastasia Shchendrygina Moscow, Russia
NCT02399137
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
- Banner MD Anderson Cancer Ctr. Gilbert, Arizona, United States
- Pacific Cancer Medical Center, Inc. Anaheim, California, United States
- St. Jude Heritage Healthcare Fullerton, California, United States
- UCLA School of Medicine Los Angeles, California, United States
NCT00730470
- Conditions
- Advanced Solid Tumors, Fibromatosis, Gingival, 2, Lethal Congenital Contracture Syndrome 2
- Locations
-
- Dana Faber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Memorial Sloan-Kettering Cancer Centre New York, United States
Active, Not Recruiting
Study of JK07 in Patients With Chronic Heart Failure
NCT06369298
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, +10 more
- Locations
-
- Site 121 Alexander City, Alabama, United States
- Site 130 Birmingham, Alabama, United States
- Site 139 Birmingham, Alabama, United States
- Site 138 Huntsville, Alabama, United States
Active, Not Recruiting
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
NCT05057013
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +80 more
- Locations
-
- Royal Marsden NHS Foundation Trust London, United Kingdom
- The Christie Hospital Manchester, United Kingdom
- Freeman Hospital, Newcastle Newcastle, United Kingdom
- Churchill Hospital Oxford, United Kingdom
Active, Not Recruiting
Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation
NCT05919537
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
- Locations
-
- GenesisCare North Shore Sydney, New South Wales, Australia
- ICON Cancer Centre South Brisbane Brisbane, Queensland, Australia
- Southern Oncology Clinical Research Unit Adelaide, South Australia, Australia
- Cabrini Health Malvern, Victoria, Australia